A much-anticipated FTC inquiry into pharmaceutical industry middlemen has been s...
BioMarin Pharmaceutical received a subpoena from the U.S. Department of Justice ...
Gonorrhea is on the rise, and growing increasingly resistant to antibiotics. Gep...
An obesity drug from Viking Therapeutics succeeded in a Phase 2 study, helping p...
The scale of the Change Healthcare cyberattack shows the risk of centralized cla...
Decisions made by the FDA more than 20 years ago have come under heightened scru...
In the wake of the Alabama court ruling, debates about “personhood” must remembe...
Palliative psychiatry is a compassionate approach that acknowledges the limits o...
Whose idea was it? New documents reveal deep divide in a dispute involving Padma...
Congress has decided not to pass a site-neutral hospital pay policy along with a...
Private equity firm New Mountain Capital has offered to purchase R1 RCM for $13....
Decades ago, Harvard botanist Richard Evans Schultes braved malaria and worse to...
Congress has abandoned its attempt to reform how PBMs operate in an upcoming pac...
The FDA is rescinding its approval of a blood cancer treatment from the Swedish ...
Oregon officials have suspended a portion of a contentious state law designed to...
A drug in development as a weight loss treatment succeeded in a Phase 2 study in...
